9th Apr 2009 15:57
Phorm, Inc. ('Phorm' or the 'Company')
AIM Block Admission
The Company (AIM: PHRM and PHRX) announces that application has been made to AIM of the London Stock Exchange plc for the block admission of up to 2,700,000 new common shares of $0.001 each in the capital of the Company, which may be allotted and issued in due course pursuant to the following schemes of the Company:
|
Name of Scheme |
Common shares issuable under each scheme as of 9 April 2009 |
Exercise Price |
|
2003 Share Plan |
2,450,000 |
£0.61327 - £27.30 |
|
2009 EMI Option Plan |
250,000 |
£3.75 |
|
TOTAL |
2,700,000 |
7,103,685 common shares of $0.001 each in the Company were originally admitted to AIM on 24 December 2004.
As of 9 April 2009, the Company had an issued share capital of 13,831,863 common shares of $0.001 each, none of which are held in treasury.
For Phorm Enquiries:
|
Phorm, Inc. |
|
|
Sarah Simon |
+44 20 7297 2433 |
|
Maria Greenwood |
+44 20 7297 2537 |
|
Citigate Dewe Rogerson |
+44 20 7638 9571 |
|
Simon Rigby |
|
|
Justin Griffiths |
|
|
Canaccord Adams Limited |
+44 20 7050 6500 |
|
(Nominated Adviser) |
|
|
Mark Williams |
|
|
Andrew Chubb |
About Phorm:
Phorm is an innovative advertising technology company specialising in interest-based advertising which preserves users' personal privacy and security. Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Ad Networks and Advertisers.
Phorm is a Delaware, US incorporated company, with offices in New York and London.
The Company was admitted to the AIM market of the London Stock Exchange in 2004 and has over 100 employees.
For more information, please visit: www.phorm.com
Related Shares:
PHRM.L